Citation

83 FR 42902

Canonical document for this Federal Register citation.

Hematologic Malignancy and Oncologic Disease: Considerations for Use of Placebos and Blinding in Randomized Controlled Clinical Trials for Drug Product Development; Draft Guidance for Industry; Availability Friday, August 24, 2018 83 FR 42902